Placental Nutrient Transport and Intrauterine Growth Restriction

Francesca Gaccioli1, Susanne Lager1

  • 1Department of Obstetrics and Gynaecology, University of Cambridge Cambridge, UK.

Frontiers in Physiology
|February 25, 2016
PubMed

Insights

Intrauterine growth restriction (IUGR) hinders fetal growth potential, impacting millions of newborns globally. Placental nutrient transporter dysfunction is a key factor in IUGR development and lifelong health issues.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Perinatology

Background:

  • Intrauterine growth restriction (IUGR) affects 5-15% of pregnancies in developed nations and up to 55% in developing countries.
  • IUGR infants face high perinatal mortality and increased risks of conditions like hypoxic ischemic encephalopathy and cerebral palsy.
  • Reduced fetal growth is linked to long-term health problems, including adult metabolic and cardiovascular diseases.

Purpose of the Study:

  • To review alterations in placental nutrient transport in human pregnancies with intrauterine growth restriction.
  • To explore the role of placental insufficiency in the etiology of IUGR.
  • To summarize changes in placental amino acid, fatty acid, and glucose transport in various IUGR-associated conditions.

Main Methods:

  • Literature review focusing on human pregnancies.
  • Analysis of studies reporting on placental nutrient transporter expression and activity.
  • Synthesis of findings related to IUGR and specific maternal conditions.

Main Results:

  • Placental insufficiency is a significant contributor to intrauterine growth restriction.
  • Reduced expression/activity of placental nutrient transporters is observed in IUGR.
  • Specific conditions like maternal undernutrition, pre-eclampsia, and infection are associated with altered placental transport.

Conclusions:

  • Dysfunctional placental nutrient transport is a critical factor in intrauterine growth restriction.
  • Understanding these transport alterations is key to addressing IUGR and its long-term consequences.
  • Further research into placental transport mechanisms can inform interventions for fetal growth disorders.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.4K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
124
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.5K